Dividend Stocks Top Wall Street Buy Lists as Investors Seek Safety
Investors seeking shelter from a turbulent market are rotating into dividend stocks at a historic clip, CNBC reported Monday, with nearly $22 billion flowing into dividend-focused exchange-traded funds in the first quarter of 2026. That marks the strongest quarterly inflow since mid-2022, according to Morningstar data.
Why Dividend Stocks Are Drawing Crowds Now
Concerns over the Iran conflict, elevated oil prices, and AI-driven disruption rattled equities through much of this year. That uncertainty pushed income-seeking investors toward steadier dividend payers. Morningstar strategist Dan Lefkovitz cautioned, however, that market timing rarely rewards those who chase the trend. A broad equity rebound, led by tech stocks with minimal dividend exposure, left some dividend buyers behind. Lefkovitz urged a buy-and-hold approach instead. He said dividend stocks remain a compelling long-run vehicle for both income and total return, but only when held through performance cycles.
A Brief History of the Dividend Trade
Dividend strategies surged in popularity during the post-2022 rate-shock period, when bonds offered competition and equity volatility punished growth names. The iShares Core High Dividend ETF, which tracks the Morningstar Dividend Yield Focus Index, became a benchmark vehicle for the strategy. That ETF formed the screening universe CNBC used to identify its current top picks.
Also Read: Fed Holds Rates Steady as Inflation Data Remains Stubbornly Mixed
Four Names Wall Street Rates as Buys
CNBC’s screen required a buy or overweight rating from at least 55% of covering analysts, upside of 15% or more to the consensus price target, and a dividend yield above 1.5%.
AbbVie topped the list with a 3.4% yield and roughly 26% implied upside, per FactSet. About 74% of analysts covering the biopharmaceutical firm rate it a buy. Bank of America analyst Jason Gerberry upgraded the stock after a first-quarter earnings beat, citing durable growth in core immunology drugs and a clean portfolio outlook through the next seven years.
Chevron follows, riding an oil-price surge to a 21% year-to-date gain. Its 3.9% yield and nearly 17% upside estimate still attract 59% buy ratings. CEO Mike Wirth told CNBC that U.S. production exceeded 200 million barrels per day for a third straight quarter, with Middle East exposure below 5% of total output.
PNC Financial Services rounds out the financials, carrying a 3.1% yield and 16.5% upside to consensus. Three-quarters of analysts covering the regional bank rate it a buy despite a revenue miss following its FirstBank acquisition.
Utility company PPL also made the screen, offering a 3.1% yield and 17% upside. Barclays analyst Michael Lonegan highlighted PPL’s above-average earnings growth trajectory and a strong economic development pipeline in a February upgrade note. The company posted an earnings beat on Friday.
Read Next: Oil Prices Surge on Iran Tensions, Energy Stocks Rally
